Over the course of this week you will be seeing multiple updates from Jim Fries on opportunities pertaining to virtual conferences that Rx-360 will be hosting, as well as updates on our next Town Hall Meetings.  Rx-360 continues to appreciate everyone’s involvement during this time, and look forward to the continued interaction and help. You and your industry colleagues are the definition of Consortium.

FDA Updates: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-daily-roundup-may-22-2020

Travel Health Notices from the CDC: https://www.cdc.gov/coronavirus/2019-ncov/travelers/map-and-travel-notices.html

COVID-19 Therapeutic Development Tracker: https://www.bio.org/policy/human-health/vaccines-biodefense/coronavirus/pipeline-tracker Special thanks to David Bricker from Eli Lilly for submitting this article for distribution.

Please don’t forget about updates to and availability of Audit Reports that can be licensed through Rx-360.  You can view our audit library at https://rx-360.org/audit-program/licensable-audit-reports/ .  For more information please contact Jaye Greene at jgreene@rx-360.org.

Rx-360 has also become a leader in transitioning audit needs to Remote, given the current pandemic.  If you need information on sponsoring an audit through Rx-360, or would like more information on our Remote Audit capabilities, please reach out to Hannah Song at hsong@rx-360.org.

Thank you again and please don’t hesitate to reach out if Rx-360 can be of any help to you or your organization during this time.